Advertisement
Screener

RECURSION PHARMACEUTICALS, INC. (RXRX) Pre-Tax Margin

RECURSION PHARMACEUTICALS, INC. (RXRX) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin -1708.03%.
  • 2026-03-31: Pre-Tax Margin -1886.71%.
  • 2025-12-31: Pre-Tax Margin -304.19%.
  • 2025-09-30: Pre-Tax Margin -3135.27%.

Complete source-backed pre-tax margin history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-30-1708.03%
2026-03-31-1886.71%
2025-12-31-304.19%
2025-09-30-3135.27%
2025-06-30-894.23%
2025-03-31-1374.33%
2024-12-31-3935.31%
2024-09-30-366.82%
2024-06-30-680.19%
2024-03-31-668.06%
2023-12-31-891.18%
2023-09-30-883.10%
2023-06-30-696.43%
2023-03-31-538.38%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-863.53%
2024-12-31-789.93%
2023-12-31-745.10%
2022-12-31-601.05%
2021-12-31-1832.18%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Vericel Corp (VCEL)United States$2.011B93.97
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Greenland Mines Ltd (GRML)United States$2.362B
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51